Gracure Pharmaceuticals Limited — Celecoxib Exporter Profile
Indian Pharmaceutical Exporter · #15 for Celecoxib · $1.9M export value · DGFT Verified
Gracure Pharmaceuticals Limited is the #15 Indian exporter of Celecoxib with $1.9M in export value and 75 verified shipments. Gracure Pharmaceuticals Limited holds a 1.4% market share in Celecoxib exports across 8 countries. The company exports 17 pharmaceutical products worth $28.1M across 9 therapeutic categories.
Gracure Pharmaceuticals Limited — Celecoxib Export Profile: Buyers & Destinations

Where Does Gracure Pharmaceuticals Limited Export Celecoxib?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BELGIUM | $386.3K | 27 | 24.7% |
| VIETNAM, DEMOCRATIC REP. OF | $328.6K | 14 | 21.0% |
| MALAYSIA | $291.8K | 12 | 18.6% |
| VIETNAM | $147.1K | 4 | 9.4% |
| CAMBODIA | $123.9K | 7 | 7.9% |
| VIETNAM DEMOCRATIC REP. OF | $109.7K | 3 | 7.0% |
| NIGERIA | $82.9K | 4 | 5.3% |
| CHILE | $50.0K | 1 | 3.2% |
| PHILIPPINES | $37.4K | 2 | 2.4% |
| AFGHANISTAN | $9.0K | 1 | 0.6% |
Gracure Pharmaceuticals Limited exports Celecoxib to 10 countries. The largest destination is BELGIUM accounting for 24.7% of Gracure Pharmaceuticals Limited's Celecoxib shipments, followed by VIETNAM, DEMOCRATIC REP. OF (21.0%) and MALAYSIA (18.6%). These destinations reflect Gracure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Celecoxib from Gracure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| A MY PHARMACEUTICAL CO., LTD | VIETNAM, DEMOCRATIC REP. OF | $200.0K | 4 |
| HEALOL PHARMACEUTICALS SDN BHD | MALAYSIA | $145.9K | 4 |
| A MY PHARMACEUTICAL CO. LIMITED | VIETNAM DEMOCRATIC REP. OF | $109.7K | 3 |
| EXPHAR SANIVELLES SUD ZONE II THINES | BELGIUM | $90.9K | 6 |
| HEALOL PHARMACEUTICALS SDN.BHD | MALAYSIA | $73.4K | 4 |
| PHUC DAN INTERNATIONAL | VIETNAM, DEMOCRATIC REP. OF | $72.7K | 4 |
| EXPHAR LAB LIMITED | NIGERIA | $71.5K | 3 |
| RATANAK RATANA PHARMACEUTICALS | CAMBODIA | $53.5K | 3 |
| DIFEM LABORATORIOS S.A | CHILE | $50.0K | 1 |
| A MY PHARMACEUTICAL CO LIMITED | VIETNAM | $50.0K | 1 |
Gracure Pharmaceuticals Limited supplies Celecoxib to 23 buyers globally. The largest buyer is A MY PHARMACEUTICAL CO., LTD (VIETNAM, DEMOCRATIC REP. OF), followed by HEALOL PHARMACEUTICALS SDN BHD (MALAYSIA) and A MY PHARMACEUTICAL CO. LIMITED (VIETNAM DEMOCRATIC REP. OF). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Celecoxib Export Value and How Much Does Gracure Pharmaceuticals Limited Contribute?
India exported $62.9M worth of Celecoxib through 4,880 shipments from 326 suppliers to 112 countries, serving 781 buyers globally. Gracure Pharmaceuticals Limited contributes $1.9M to this total, accounting for 1.4% of India's Celecoxib exports. Gracure Pharmaceuticals Limited ships Celecoxib to 10 countries through 23 buyers.
What Is the Average Shipment Value for Gracure Pharmaceuticals Limited's Celecoxib Exports?
Gracure Pharmaceuticals Limited's average Celecoxib shipment value is $25.5K per consignment, based on 75 shipments totaling $1.9M. The largest destination is BELGIUM (24.7% of Gracure Pharmaceuticals Limited's Celecoxib exports).
How Does Gracure Pharmaceuticals Limited Compare to Other Indian Celecoxib Exporters?
Gracure Pharmaceuticals Limited ranks #15 among 326 Indian Celecoxib exporters with a 1.4% market share. The top 3 exporters are ALEMBIC PHARMACEUTICALS LIMITED ($12.2M), CIPLA LIMITED ($12.2M), MACLEODS PHARMACEUTICALS LTD ($9.2M). Gracure Pharmaceuticals Limited processed 75 shipments to 8 destination countries.
What Celecoxib Formulations Does Gracure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| GRACOX(CELECOXIB CAPSULES 200MG)3X10/BOXB.NO.AC240020A TO AC240022AAC240025A TO AC240027ANOS | $109.7K | 3 |
| GRACOX (CELECOXIB CAPSULES 200 MG ) 3X10 | $100.0K | 2 |
| EXXIB ( CELECOXIB TABLETS 200MG )B/10 B | $60.0K | 3 |
| CELECOXIB CAPSULES 200 MG 3X10/ BOX | $50.0K | 1 |
| GRACOX ( CELECOXIB CAPSULES 200 MG )3X10 | $50.0K | 1 |
| GRACOX CELECOXIB CAPSULES 200 MG 3 X10 BOX | $50.0K | 1 |
| GRACOX (CELECOXIB CAPSULES 200 MG ) 3X10/BOX | $50.0K | 1 |
| EXXIB ( CELECOXIB TABLETS 200MG )B/10 | $50.0K | 1 |
| FUXICURE -400(CELECOXIB CAP.400MG)3X10/BOX,B.NO AC240074A TO AC240077A,M.DT.01/04/24,02/04/24,EXP.DT.31/03/27,01/04/27 | $46.0K | 3 |
| FUXICURE-400 (CELECOXIB CAPSULES 400MG)3 | $41.9K | 2 |
Gracure Pharmaceuticals Limited exports 56 distinct Celecoxib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is GRACOX(CELECOXIB CAPSULES 200MG)3X10/BOXB.NO.AC240020A TO AC with 3 shipments worth $109.7K.
How Does Gracure Pharmaceuticals Limited Compare to Nearest Celecoxib Exporters?
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $2.8M | 127 | 9 | $22.0K |
| 12 | EMCURE PHARMACEUTICALS LIMITED | $2.3M | 146 | 1 | $15.7K |
| 15 | GRACURE PHARMACEUTICALS LIMITED ★ | $1.9M | 75 | 8 | $25.5K |
| 6 | BDH HEALTHCARE PRIVATE LIMITED | $1.1M | 23 | 1 | $50.0K |
| 13 | BDH INDUSTRIES LIMITED | $850.0K | 17 | 1 | $50.0K |
Gracure Pharmaceuticals Limited ranks #15 among 326 Indian Celecoxib exporters. Average shipment value of $25.5K compared to the market average of $192.8K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and EMCURE PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Celecoxib Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 544 | 11.1% |
| DELHI AIR CARGO ACC (INDEL4) | 475 | 9.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 433 | 8.9% |
| SAHAR AIR | 323 | 6.6% |
| JNPT/ NHAVA SHEVA SEA | 305 | 6.3% |
| DELHI AIR | 256 | 5.2% |
| JNPT | 216 | 4.4% |
| MUNDRA SEA | 196 | 4.0% |
What Other Analgesics & Antipyretics Products Does Gracure Pharmaceuticals Limited Export?
Gracure Pharmaceuticals Limited also exports these analgesics & antipyretics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Gracure Pharmaceuticals Limited's Celecoxib Exports
Recent geopolitical tensions, particularly in the Middle East, have significantly impacted global shipping routes. The Red Sea crisis and Houthi attacks have led to increased shipping costs and extended transit times for Indian exporters. Major carriers have suspended or restricted transits through the Red Sea–Suez Canal corridor, resulting in transit times extending by 10–20 days and freight rates rising by 40–50% on key India–Europe routes. (livemint.com)
For Gracure Pharmaceuticals, which relies heavily on maritime routes for its exports, these disruptions pose challenges in maintaining timely deliveries and managing increased operational costs. Additionally, the U.S.–India diplomatic and trade crisis, marked by the imposition of tariffs on Indian exports, further complicates the export landscape. The U.S. administration imposed a 25% "reciprocal" tariff, followed by an additional 25% penalty tied to India's continued imports of Russian oil, bringing the total duty to 50%. (en.wikipedia.org) These developments necessitate strategic adjustments to mitigate potential revenue losses and sustain market competitiveness.
Gracure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Gracure Pharmaceuticals has secured approvals and clearances from various international regulatory bodies, reflecting its commitment to quality and safety. However, evolving regulations, such as the European Union's falsified medicines directive, impose additional compliance requirements. Adhering to these standards is crucial for maintaining market access and consumer trust.
Furthermore, the U.S. Food and Drug Administration (FDA) has intensified scrutiny of foreign pharmaceutical manufacturers. Ensuring compliance with FDA regulations is essential for Gracure to sustain and expand its presence in the lucrative U.S. market.
About Gracure Pharmaceuticals Limited
Gracure Pharmaceuticals Limited exports 17 products worth $28.1M. Beyond Celecoxib, top products include Tramadol, Albendazole, Folic, Melatonin, Doxycycline. View the complete Gracure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Celecoxib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Celecoxib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Gracure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 75 individual customs records matching Gracure Pharmaceuticals Limited exporting Celecoxib, covering 56 formulations to 10 countries via 23 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 112+ countries, 781+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Celecoxib Export Data from Gracure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Gracure Pharmaceuticals Limited's Celecoxib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Gracure Pharmaceuticals Limited
Full Company Profile →
17 products · $28.1M total trade · 9 categories
Celecoxib Stats
Company Overview
Top Products by Gracure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Gracure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Celecoxib. For current shipment-level data, contact TransData Nexus.